GO:0008017 | microtubule binding | 8.33% (15/180) | 4.88 | 0.0 | 0.0 |
GO:0015631 | tubulin binding | 8.33% (15/180) | 4.76 | 0.0 | 0.0 |
GO:0008092 | cytoskeletal protein binding | 8.33% (15/180) | 4.67 | 0.0 | 0.0 |
GO:0003774 | motor activity | 8.33% (15/180) | 4.39 | 0.0 | 0.0 |
GO:0007018 | microtubule-based movement | 7.22% (13/180) | 4.43 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 7.22% (13/180) | 4.44 | 0.0 | 0.0 |
GO:0006928 | movement of cell or subcellular component | 7.22% (13/180) | 4.39 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 7.22% (13/180) | 4.28 | 0.0 | 0.0 |
GO:0017111 | nucleoside-triphosphatase activity | 9.44% (17/180) | 2.81 | 0.0 | 0.0 |
GO:0016462 | pyrophosphatase activity | 9.44% (17/180) | 2.77 | 0.0 | 0.0 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 9.44% (17/180) | 2.76 | 0.0 | 0.0 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 9.44% (17/180) | 2.75 | 0.0 | 0.0 |
GO:0005524 | ATP binding | 13.89% (25/180) | 2.07 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 13.89% (25/180) | 2.06 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 13.89% (25/180) | 2.06 | 0.0 | 0.0 |
GO:0008144 | drug binding | 13.89% (25/180) | 2.01 | 0.0 | 0.0 |
GO:0035639 | purine ribonucleoside triphosphate binding | 14.44% (26/180) | 1.92 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 14.44% (26/180) | 1.91 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 14.44% (26/180) | 1.9 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 14.44% (26/180) | 1.87 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 14.44% (26/180) | 1.87 | 0.0 | 0.0 |
GO:0043168 | anion binding | 14.44% (26/180) | 1.75 | 0.0 | 1e-06 |
GO:1901265 | nucleoside phosphate binding | 14.44% (26/180) | 1.74 | 0.0 | 1e-06 |
GO:0000166 | nucleotide binding | 14.44% (26/180) | 1.74 | 0.0 | 1e-06 |
GO:0036094 | small molecule binding | 14.44% (26/180) | 1.69 | 0.0 | 1e-06 |
GO:0005515 | protein binding | 15.56% (28/180) | 1.45 | 1e-06 | 1.2e-05 |
GO:0043167 | ion binding | 15.56% (28/180) | 1.38 | 3e-06 | 3e-05 |
GO:1901363 | heterocyclic compound binding | 16.67% (30/180) | 1.27 | 6e-06 | 5.6e-05 |
GO:0097159 | organic cyclic compound binding | 16.67% (30/180) | 1.27 | 6e-06 | 5.6e-05 |
GO:0008290 | F-actin capping protein complex | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0030835 | negative regulation of actin filament depolymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0030837 | negative regulation of actin filament polymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:1901880 | negative regulation of protein depolymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0051693 | actin filament capping | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0031333 | negative regulation of protein complex assembly | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:1901879 | regulation of protein depolymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0032272 | negative regulation of protein polymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0051016 | barbed-end actin filament capping | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:1902904 | negative regulation of supramolecular fiber organization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0043242 | negative regulation of protein complex disassembly | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0030834 | regulation of actin filament depolymerization | 1.11% (2/180) | 7.1 | 5.3e-05 | 0.000323 |
GO:0016787 | hydrolase activity | 10.56% (19/180) | 1.44 | 7.8e-05 | 0.000458 |
GO:0005488 | binding | 24.44% (44/180) | 0.83 | 7.7e-05 | 0.000463 |
GO:0043244 | regulation of protein complex disassembly | 1.11% (2/180) | 6.52 | 0.000158 | 0.000879 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.11% (2/180) | 6.52 | 0.000158 | 0.000879 |
GO:0016043 | cellular component organization | 3.33% (6/180) | 2.79 | 0.000242 | 0.00132 |
GO:0071840 | cellular component organization or biogenesis | 3.33% (6/180) | 2.65 | 0.000405 | 0.002165 |
GO:0010639 | negative regulation of organelle organization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0032970 | regulation of actin filament-based process | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0032535 | regulation of cellular component size | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0030832 | regulation of actin filament length | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0032271 | regulation of protein polymerization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0030833 | regulation of actin filament polymerization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0043254 | regulation of protein complex assembly | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:1902903 | regulation of supramolecular fiber organization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0051129 | negative regulation of cellular component organization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0110053 | regulation of actin filament organization | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0090066 | regulation of anatomical structure size | 1.11% (2/180) | 5.78 | 0.00052 | 0.002177 |
GO:0044446 | intracellular organelle part | 4.44% (8/180) | 2.13 | 0.000529 | 0.002178 |
GO:0044422 | organelle part | 4.44% (8/180) | 2.11 | 0.000587 | 0.002377 |
GO:0044430 | cytoskeletal part | 2.22% (4/180) | 3.37 | 0.000604 | 0.002408 |
GO:0051493 | regulation of cytoskeleton organization | 1.11% (2/180) | 5.52 | 0.000777 | 0.003047 |
GO:0044815 | DNA packaging complex | 2.22% (4/180) | 3.24 | 0.000851 | 0.003287 |
GO:0044087 | regulation of cellular component biogenesis | 1.11% (2/180) | 5.29 | 0.001083 | 0.004117 |
GO:0051276 | chromosome organization | 1.67% (3/180) | 3.78 | 0.001337 | 0.005007 |
GO:0044427 | chromosomal part | 2.22% (4/180) | 2.93 | 0.001907 | 0.00704 |
GO:0009987 | cellular process | 15.0% (27/180) | 0.81 | 0.003031 | 0.011024 |
GO:0033043 | regulation of organelle organization | 1.11% (2/180) | 4.52 | 0.003322 | 0.011911 |
GO:0006996 | organelle organization | 1.67% (3/180) | 3.19 | 0.004313 | 0.015247 |
GO:0048523 | negative regulation of cellular process | 1.11% (2/180) | 4.19 | 0.005209 | 0.017669 |
GO:0051128 | regulation of cellular component organization | 1.11% (2/180) | 4.19 | 0.005209 | 0.017669 |
GO:0071103 | DNA conformation change | 1.11% (2/180) | 4.19 | 0.005209 | 0.017669 |
GO:0016459 | myosin complex | 1.11% (2/180) | 4.1 | 0.005925 | 0.019829 |
GO:0000786 | nucleosome | 1.67% (3/180) | 2.88 | 0.007948 | 0.025907 |
GO:0032993 | protein-DNA complex | 1.67% (3/180) | 2.88 | 0.007948 | 0.025907 |
GO:0048519 | negative regulation of biological process | 1.11% (2/180) | 3.85 | 0.008323 | 0.026783 |
GO:0044424 | intracellular part | 5.56% (10/180) | 1.26 | 0.009657 | 0.030681 |
GO:0032991 | protein-containing complex | 4.44% (8/180) | 1.39 | 0.012165 | 0.038168 |
GO:0007076 | mitotic chromosome condensation | 0.56% (1/180) | 6.1 | 0.014521 | 0.043913 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 0.56% (1/180) | 6.1 | 0.014521 | 0.043913 |
GO:0000796 | condensin complex | 0.56% (1/180) | 6.1 | 0.014521 | 0.043913 |
GO:0044464 | cell part | 5.56% (10/180) | 1.14 | 0.016312 | 0.048741 |